488 related articles for article (PubMed ID: 29309431)
1. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.
Carmalt JL; Mortazavi S; McOnie RC; Allen AL; Unniappan S
PLoS One; 2018; 13(1):e0190796. PubMed ID: 29309431
[TBL] [Abstract][Full Text] [Related]
2. PC1/3 and PC2 gene expression and post-translational endoproteolytic pro-opiomelanocortin processing is regulated by photoperiod in the seasonal Siberian hamster (Phodopus sungorus).
Helwig M; Khorooshi RM; Tups A; Barrett P; Archer ZA; Exner C; Rozman J; Braulke LJ; Mercer JG; Klingenspor M
J Neuroendocrinol; 2006 Jun; 18(6):413-25. PubMed ID: 16684131
[TBL] [Abstract][Full Text] [Related]
3. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
McFarlane D; Beech J; Cribb A
Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin.
Marcinkiewicz M; Day R; Seidah NG; Chrétien M
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4922-6. PubMed ID: 8389457
[TBL] [Abstract][Full Text] [Related]
5. Obliteration of alpha-melanocyte-stimulating hormone derived from POMC in pituitary and brains of PC2-deficient mice.
Miller R; Aaron W; Toneff T; Vishnuvardhan D; Beinfeld MC; Hook VY
J Neurochem; 2003 Aug; 86(3):556-63. PubMed ID: 12859669
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses.
Mc Gowan TW; Pinchbeck GP; Mc Gowan CM
Equine Vet J; 2013 Jan; 45(1):66-73. PubMed ID: 22563728
[TBL] [Abstract][Full Text] [Related]
7. Expression of three proopiomelanocortin subtype genes and mass spectrometric identification of POMC-derived peptides in pars distalis and pars intermedia of barfin flounder pituitary.
Takahashi A; Amano M; Amiya N; Yamanome T; Yamamori K; Kawauchi H
Gen Comp Endocrinol; 2006 Feb; 145(3):280-6. PubMed ID: 16242690
[TBL] [Abstract][Full Text] [Related]
8. Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene.
Low MJ; Liu B; Hammer GD; Rubinstein M; Allen RG
J Biol Chem; 1993 Nov; 268(33):24967-75. PubMed ID: 8227058
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
10. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing.
Zhou A; Bloomquist BT; Mains RE
J Biol Chem; 1993 Jan; 268(3):1763-9. PubMed ID: 8380577
[TBL] [Abstract][Full Text] [Related]
11. The effect of geographic location, breed, and pituitary dysfunction on seasonal adrenocorticotropin and α-melanocyte-stimulating hormone plasma concentrations in horses.
McFarlane D; Paradis MR; Zimmel D; Sykes B; Brorsen BW; Sanchez A; Vainio K
J Vet Intern Med; 2011; 25(4):872-81. PubMed ID: 21745243
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin.
Mazurkiewicz JE; Corliss D; Slominski A
J Histochem Cytochem; 2000 Jul; 48(7):905-14. PubMed ID: 10858267
[TBL] [Abstract][Full Text] [Related]
13. Expression of proopiomelanocortin and prohormone convertase-1 and -2 in the late gestation fetal sheep pituitary.
Bell ME; Myers TR; Myers DA
Endocrinology; 1998 Dec; 139(12):5135-43. PubMed ID: 9832453
[TBL] [Abstract][Full Text] [Related]
14. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
15. Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2.
Nie Y; Ferrini MG; Liu Y; Anghel A; Paez Espinosa EV; Stuart RC; Lutfy K; Nillni EA; Friedman TC
Peptides; 2013 Sep; 47():99-109. PubMed ID: 23891651
[TBL] [Abstract][Full Text] [Related]
16. Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA.
Bloomquist BT; Eipper BA; Mains RE
Mol Endocrinol; 1991 Dec; 5(12):2014-24. PubMed ID: 1791845
[TBL] [Abstract][Full Text] [Related]
17. Loss of hypothalamic Furin affects POMC to proACTH cleavage and feeding behavior in high-fat diet-fed mice.
Coppola I; Brouwers B; Walker L; Alar C; Meulemans S; White A; Ramos-Molina B; Creemers JWM
Mol Metab; 2022 Dec; 66():101627. PubMed ID: 36374777
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice.
Laurent V; Jaubert-Miazza L; Desjardins R; Day R; Lindberg I
Endocrinology; 2004 Feb; 145(2):519-28. PubMed ID: 14576186
[TBL] [Abstract][Full Text] [Related]
19. In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3).
Friedman TC; Loh YP; Birch NP
Endocrinology; 1994 Sep; 135(3):854-62. PubMed ID: 8070378
[TBL] [Abstract][Full Text] [Related]
20. Structure and expression of Xenopus prohormone convertase PC2.
Braks JA; Guldemond KC; van Riel MC; Coenen AJ; Martens GJ
FEBS Lett; 1992 Jun; 305(1):45-50. PubMed ID: 1633858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
